- ►annals.org [PDF] EJ Suh-Burgmann, A Goodman - Annals of internal medicine, 1999 - Am Coll Physicians Recent studies showing a protective effect of tamoxifen in women at high risk
for breast cancer have expanded the indications of the drug. While acting as an
estrogen antag- onist in the breast, tamoxifen can have estrogenic effects ... Cited by 52 - Related articles - BL Direct - All 6 versions
- ►ascopubs.org CDB Love, BB Muir, JB Scrimgeour, RCF … - Journal of Clinical Oncology, 1999 - jco.ascopubs.org PURPOSE: Tamoxifen is the most commonly prescribed adjuvant therapy for women
with breast cancer. It has agonist activity on the endometrium and is associated
with an increased risk of endometrial cancer. The aim of this study was to ... Cited by 105 - Related articles - BL Direct - All 6 versions
- ►ascopubs.org RR Barakat, TA Gilewski, L Almadrones, PE … - Journal of Clinical Oncology, 2000 - jco.ascopubs.org RESULTS: One hundred fifty-nine patients with a median age of 50 years were
entered onto study. Patients were assessable if EMBs were performed at least 1
year after the initiation of tamoxifen treatment. Nine patients (5.7%) were ... Cited by 70 - Related articles - BL Direct - All 8 versions
- ►jcojournal.org B Gerber, A Krause, H Muller, T Reimer, T Kulz … - Journal of Clinical Oncology, 2000 - jcojournal.org Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
From the Department of Obstetrics and Gynecology, Department of Pathology, ... Cited by 108 - Related articles - BL Direct - All 11 versions
M Seoud, A Shamseddine, A Khalil, Z Salem, N … - Gynecologic Oncology, 1999 - Elsevier Results. Nine women were lost to follow-up prior to initiation of treatment and
4 refused biopsies, leaving 67 patients for evaluation. Fifty (74.6%) of the 67
patients were already on tamoxifen for a mean duration of 15.8 ± 16.6 ... Cited by 39 - Related articles - BL Direct - All 5 versions
M Berliere, A Charles, C Galant, J Donnez - OBSTETRICS AND GYNECOLOGY-NEW YORK-, 1998 - Am Coll Ob/Gyn Uterine Side Effects of Tamoxifen: A Need for Systematic Pretreatment Screening
MARTINE BERLIÈRE, MD, ALAIN CHARLES, MD, CHRISTINE GALANT, MD, AND JACQUES
DONNEZ, MD, PhD Objective: To determine the effect of tamoxifen on the ... Cited by 93 - Related articles - BL Direct - All 8 versions
S Cecchini, S Ciatto, R Bonardi, A Mazzotta, … - Gynecologic Oncology, 1996 - Elsevier Seven-hundred thirty-seven asymptomatic postmenopausal breast cancer patients
under long-term adjuvant tamoxifen therapy (average, 50 months) were screened by
endometrial ultrasonography. Abnormal endometrial thickness (6 mm or ... Cited by 36 - Related articles - BL Direct - All 4 versions
RR Barakat - Journal of Clinical Oncology, 1999 - jcojournal.org APPROXIMATELY 80,000 OF the 182,000 women diagnosed annually with breast cancer
in the United States will be started on tamoxifen as part of their treatment.
Although the expected annual risk of developing endometrial cancer while ... Cited by 27 - Related articles - BL Direct - All 6 versions
M Franchi, F Ghezzi, N Donadello, F Zanaboni, … - Obstetrics & Gynecology, 1999 - journals.lww.com Objective: To assess the independent contribution of trans- vaginal ultrasound
in identifying women at risk for endo- metrial disorders, and determine whether
a cutoff value identifies women who need endometrial histologic assess- ... Cited by 39 - Related articles - BL Direct - All 5 versions
- ►bmj.com [PDF] I Cohen, E Perel, D Flex, R Tepper, MM … - British Medical Journal, 1999 - jcp.bmj.com Abstract Aims—To evaluate whether endometrial pathology is more likely to be
diagnosed in gynaecologically symptomatic rather than in gynaecologically
asymptomatic post- menopausal breast cancer patients with tamoxifen ... Cited by 31 - Related articles - BL Direct - All 6 versions
